Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» antibody-drug conjugate
antibody-drug conjugate
JPM24 opens with ADCs the hottest ticket in San Francisco
Fierce Biotech
Mon, 01/8/24 - 11:21 am
JPMHC 2024
antibody-drug conjugate
venture capital
Roche Signs Potential $1B ADC Cancer Deal with China’s MediLink
BioSpace
Wed, 01/3/24 - 09:36 am
Roche
MediLink Therapeutics
oncology
antibody-drug conjugate
Inside AbbVie's $10B buyout of ImmunoGen—and the bidding war it swooped in on
Fierce Pharma
Tue, 01/2/24 - 10:11 pm
AbbVie
Immunogen
M&A
antibody-drug conjugate
Sanofi’s oncology strategy suffers another blow as ADC scrapped over phase 3 lung cancer fail
Fierce Biotech
Thu, 12/21/23 - 09:40 am
Sanofi
antibody-drug conjugate
lung cancer
clinical trials
tusamitamab ravtansine
Immunogen
GSK heads back to Hansoh, paying $185M upfront for another ADC
Fierce Biotech
Wed, 12/20/23 - 09:46 am
GSK
Hansoh Pharmaceutical
antibody-drug conjugate
Bristol Myers pays SystImmune $800M and adds to pharma’s ‘ADC’ deal spree
BioPharma Dive
Tue, 12/12/23 - 09:58 am
Bristol Myers Squibb
SystImmune
antibody-drug conjugate
cancer
ADC and GLP-1 Rocket Ride Continues as 2023 Comes to Close
BioSpace
Sun, 12/3/23 - 09:34 pm
antibody-drug conjugate
GLP-1 agonist
AbbVie Gets Phase II NSCLC Win for ADC, Looks to Accelerated Approval
BioSpace
Fri, 12/1/23 - 11:23 am
AbbVie
Teliso-V
antibody-drug conjugate
non-small cell lung cancer
AbbVie pays $10B to acquire ImmunoGen, doubling down on red-hot ADC cancer field
Fierce Pharma
Thu, 11/30/23 - 10:20 am
AbbVie
M&A
antibody-drug conjugate
Immunogen
Elahere
ovarian cancer
Regeneron stays out of ADC deal fray as in-house scientists tinker
Fierce Biotech
Wed, 11/15/23 - 11:08 am
Regeneron
antibody-drug conjugate
Merck and Bristol Myers Squibb Will Face Off in This 1 Market -- but Who Will Win?
Motley Fool
Sun, 11/12/23 - 09:30 pm
Merck
Bristol Myers Squibb
antibody-drug conjugate
Bristol Myers pays $100M for a different kind of ADC
BioPharma Dive
Mon, 11/6/23 - 09:54 am
Bristol Myers Squibb
antibody-drug conjugate
bone cancer
blood cancer
Orum Therapeutics
Daiichi-Sankyo ups revenue forecast thanks to massive Merck deal
Fierce Biotech
Tue, 10/31/23 - 09:30 pm
Daiichi Sankyo
Merck
antibody-drug conjugate
‘We knew it was there’: AbbVie CEO says company favored internal work over potential Daiichi deal
Fierce Biotech
Sun, 10/29/23 - 08:56 pm
AbbVie
Daiichi Sankyo
Merck
antibody-drug conjugate
ESMO: Ambrx's 'reset' arrives at the last line of prostate cancer, offering the kind of safety rarely seen
Fierce Biotech
Mon, 10/23/23 - 10:33 am
ESMO
Ambrx
prostate cancer
ARX517
antibody-drug conjugate
In 2nd big ADC deal of the day, GSK inks $2B-plus pact for Hansoh gynecology cancer asset
Fierce Biotech
Sun, 10/22/23 - 06:13 pm
GSK
antibody-drug conjugate
Hansoh Pharmaceutical
ESMO: Seagen and Genmab's Tivdak keeps cervical cancer patients alive longer
Fierce Pharma
Sun, 10/22/23 - 06:11 pm
ESMO
Pfizer
Seagen
cervical cancer
antibody-drug conjugate
Merck pays $4B upfront for rights to 3 Daiichi ADCs in huge bet on post-Keytruda future
Fierce Biotech
Fri, 10/20/23 - 09:55 am
Merck
Daiichi Sankyo
AstraZeneca
antibody-drug conjugate
Lilly links up European ADC network, snagging Elahere rival in latest biotech buy
Fierce Biotech
Thu, 10/19/23 - 10:10 am
Eli Lilly
M&A
antibody-drug conjugate
Elahere
Mablink
BioNTech Inks Potential $1B Deal with MediLink for Cancer-Focused ADCs
BioSpace
Fri, 10/13/23 - 11:56 am
BioNTech
MediLink
cancer
antibody-drug conjugate
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »